type here...

CATEGORIES

Press Release

LATEST

1...101112Page 12 of 12

TRENDING

EDITORS CHOICE

Study Reveals Networks of Genes Involved in Congenital Heart Disease

Medika Life -
Over two million babies, children, and adults in the United States are living with congenital heart disease—a range of birth defects affecting the heart's structure or function

HealthTap Launches Care Orchestration to Drive Timely Use of Employee Benefits

Medika Life -
With Care Orchestration, HealthTap doctors maximize the value of employee benefits through recommendations at point-of-care

FDA Approves THERMOCOOL SMARTTOUCH® SF Ablation Catheter

Medika Life -
The CARTO® 3 System and THERMOCOOL SMARTTOUCH® SF Catheter allow for a patient-tailored ablation approach, resulting in high long-term effectiveness in persistent atrial fibrillation patients

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Medika Life -
SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories